| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP36 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L23 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.74e-28 | 114 | 42 | 17 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP36 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L23 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 2.17e-27 | 124 | 42 | 17 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP36 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L23 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.31e-26 | 137 | 42 | 17 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP36 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L23 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 5.15e-24 | 192 | 42 | 17 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP36 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L23 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 5.56e-15 | 654 | 42 | 17 | GO:0008233 |
| GeneOntologyMolecularFunction | ethanol binding | 1.72e-07 | 6 | 42 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | protein-cysteine S-stearoyltransferase activity | 3.01e-07 | 7 | 42 | 3 | GO:0140439 | |
| GeneOntologyMolecularFunction | calcium,diacylglycerol-dependent serine/threonine kinase activity | 4.32e-06 | 2 | 42 | 2 | GO:0004698 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.70e-05 | 24 | 42 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 2.18e-05 | 26 | 42 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 2.18e-05 | 26 | 42 | 3 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 2.18e-05 | 26 | 42 | 3 | GO:0019707 | |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 3.38e-05 | 30 | 42 | 3 | GO:0016417 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 3.38e-05 | 30 | 42 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 6.40e-05 | 37 | 42 | 3 | GO:0016409 | |
| GeneOntologyMolecularFunction | protein-cysteine S-myristoyltransferase activity | 6.44e-05 | 6 | 42 | 2 | GO:0019705 | |
| GeneOntologyMolecularFunction | zinc ion binding | 7.95e-05 | 891 | 42 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | transition metal ion binding | PRKCA ZDHHC20 PRKCG ZDHHC15 TRAFD1 FN1 ADH1A ADH1B MIB1 ADH1C | 1.38e-04 | 1189 | 42 | 10 | GO:0046914 |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine kinase activity | 1.92e-04 | 10 | 42 | 2 | GO:0009931 | |
| GeneOntologyMolecularFunction | myristoyltransferase activity | 2.35e-04 | 11 | 42 | 2 | GO:0019107 | |
| GeneOntologyMolecularFunction | NAD binding | 4.86e-04 | 73 | 42 | 3 | GO:0051287 | |
| GeneOntologyMolecularFunction | integrin binding | 4.92e-04 | 175 | 42 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 5.09e-04 | 16 | 42 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.29e-03 | 102 | 42 | 3 | GO:0043178 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 1.69e-03 | 29 | 42 | 2 | GO:0005540 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.38e-03 | 268 | 42 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.41e-03 | 127 | 42 | 3 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 3.04e-03 | 138 | 42 | 3 | GO:0016614 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.20e-03 | 188 | 42 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.36e-02 | 238 | 42 | 3 | GO:0016747 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP36 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.11e-25 | 125 | 41 | 16 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP36 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.20e-24 | 144 | 41 | 16 | GO:0070646 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP36 USP17L6P USP17L5 PRKCA USP17L21 PRKCG RFFL USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 MIB1 | 1.71e-15 | 1074 | 41 | 20 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP36 USP17L6P USP17L5 USP17L21 PRKCG RFFL USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 MIB1 | 9.38e-15 | 1009 | 41 | 19 | GO:0070647 |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 7.29e-09 | 3 | 41 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 7.27e-08 | 5 | 41 | 3 | GO:0006117 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 4.86e-06 | 17 | 41 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 4.86e-06 | 17 | 41 | 3 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 5.83e-06 | 18 | 41 | 3 | GO:0006067 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 1.26e-05 | 23 | 41 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 1.43e-05 | 24 | 41 | 3 | GO:0018231 | |
| GeneOntologyBiologicalProcess | peptidyl-L-cysteine S-palmitoylation | 1.43e-05 | 24 | 41 | 3 | GO:0018230 | |
| GeneOntologyBiologicalProcess | aldehyde biosynthetic process | 3.15e-05 | 31 | 41 | 3 | GO:0046184 | |
| GeneOntologyBiologicalProcess | protein palmitoylation | 3.82e-05 | 33 | 41 | 3 | GO:0018345 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 6.84e-05 | 40 | 41 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 1.07e-04 | 8 | 41 | 2 | GO:0071947 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 1.11e-04 | 47 | 41 | 3 | GO:0046164 | |
| GeneOntologyBiologicalProcess | peptidyl-cysteine modification | 1.34e-04 | 50 | 41 | 3 | GO:0018198 | |
| GeneOntologyBiologicalProcess | response to testosterone | 1.59e-04 | 53 | 41 | 3 | GO:0033574 | |
| GeneOntologyBiologicalProcess | retinol metabolic process | 1.59e-04 | 53 | 41 | 3 | GO:0042572 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 2.51e-04 | 12 | 41 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | response to ethanol | 2.89e-04 | 161 | 41 | 4 | GO:0045471 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 4.12e-04 | 73 | 41 | 3 | GO:1901616 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 7.35e-04 | 89 | 41 | 3 | GO:0001523 | |
| GeneOntologyBiologicalProcess | protein targeting | 8.26e-04 | 373 | 41 | 5 | GO:0006605 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 8.62e-04 | 94 | 41 | 3 | GO:0016101 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 8.89e-04 | 95 | 41 | 3 | GO:0006081 | |
| GeneOntologyBiologicalProcess | protein lipidation | 1.06e-03 | 101 | 41 | 3 | GO:0006497 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.19e-03 | 105 | 41 | 3 | GO:0006721 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 1.22e-03 | 106 | 41 | 3 | GO:0042158 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.22e-03 | 106 | 41 | 3 | GO:0034308 | |
| GeneOntologyBiologicalProcess | protein acylation | 1.29e-03 | 108 | 41 | 3 | GO:0043543 | |
| GeneOntologyBiologicalProcess | regulation of response to food | 1.31e-03 | 27 | 41 | 2 | GO:0032095 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 1.32e-03 | 109 | 41 | 3 | GO:0034446 | |
| GeneOntologyBiologicalProcess | synaptic vesicle maturation | 1.51e-03 | 29 | 41 | 2 | GO:0016188 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 USP17L6P USP17L5 ZDHHC20 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 ZDHHC6 USP17L11 USP17L15 USP17L13 USP17L18 | 1.51e-09 | 1293 | 42 | 16 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 USP17L6P USP17L5 ZDHHC20 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 ZDHHC6 USP17L11 USP17L15 USP17L13 USP17L18 | 1.61e-09 | 1299 | 42 | 16 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L6P USP17L5 ZDHHC20 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 ZDHHC6 USP17L11 USP17L15 USP17L13 USP17L18 | 2.19e-09 | 1327 | 42 | 16 | GO:0042175 |
| GeneOntologyCellularComponent | basement membrane | 1.04e-04 | 122 | 42 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 1.76e-04 | 10 | 42 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | calyx of Held | 2.38e-03 | 36 | 42 | 2 | GO:0044305 | |
| MousePheno | enhanced behavioral response to alcohol | 1.20e-08 | 16 | 24 | 4 | MP:0009751 | |
| MousePheno | abnormal behavioral response to alcohol | 6.94e-08 | 24 | 24 | 4 | MP:0020157 | |
| MousePheno | abnormal ethanol metabolism | 8.86e-08 | 6 | 24 | 3 | MP:0005443 | |
| MousePheno | abnormal retinol metabolism | 1.55e-07 | 7 | 24 | 3 | MP:0005444 | |
| MousePheno | enhanced behavioral response to addictive substance | 8.66e-07 | 44 | 24 | 4 | MP:0009749 | |
| MousePheno | abnormal vitamin A metabolism | 2.00e-06 | 15 | 24 | 3 | MP:0011233 | |
| MousePheno | abnormal vitamin metabolism | 2.00e-06 | 15 | 24 | 3 | MP:0013244 | |
| MousePheno | abnormal vitamin or vitamin cofactor metabolism | 2.00e-06 | 15 | 24 | 3 | MP:0013274 | |
| MousePheno | enhanced behavioral response to xenobiotic | 5.36e-06 | 69 | 24 | 4 | MP:0009746 | |
| MousePheno | abnormal behavioral response to addictive substance | 2.54e-05 | 102 | 24 | 4 | MP:0009748 | |
| MousePheno | increased trophectoderm apoptosis | 7.86e-05 | 8 | 24 | 2 | MP:0012119 | |
| MousePheno | increased embryonic tissue cell apoptosis | 1.24e-04 | 153 | 24 | 4 | MP:0013504 | |
| MousePheno | decreased regulatory T cell number | 1.73e-04 | 64 | 24 | 3 | MP:0004974 | |
| MousePheno | failure of chorioallantoic fusion | 1.98e-04 | 67 | 24 | 3 | MP:0009657 | |
| MousePheno | abnormal embryonic tissue cell apoptosis | 2.31e-04 | 180 | 24 | 4 | MP:0013503 | |
| MousePheno | abnormal extraembryonic tissue physiology | 2.57e-04 | 345 | 24 | 5 | MP:0004264 | |
| MousePheno | abnormal chorioallantoic fusion | 4.74e-04 | 90 | 24 | 3 | MP:0002824 | |
| MousePheno | increased thymus weight | 7.62e-04 | 24 | 24 | 2 | MP:0004955 | |
| MousePheno | abnormal mast cell number | 9.66e-04 | 27 | 24 | 2 | MP:0020203 | |
| MousePheno | abnormal regulatory T cell number | 9.68e-04 | 115 | 24 | 3 | MP:0004972 | |
| MousePheno | abnormal regulatory T cell morphology | 1.02e-03 | 117 | 24 | 3 | MP:0004941 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L5 USP17L21 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 1.89e-30 | 16 | 39 | 12 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L5 USP17L21 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 1.89e-30 | 16 | 39 | 12 | IPR006861 |
| Domain | USP_CS | USP17L7 USP36 USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 1.53e-25 | 66 | 39 | 14 | IPR018200 |
| Domain | USP_1 | USP17L7 USP36 USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 3.79e-25 | 70 | 39 | 14 | PS00972 |
| Domain | UCH | USP17L7 USP36 USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 4.71e-25 | 71 | 39 | 14 | PF00443 |
| Domain | USP_2 | USP17L7 USP36 USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 4.71e-25 | 71 | 39 | 14 | PS00973 |
| Domain | USP_3 | USP17L7 USP36 USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 5.84e-25 | 72 | 39 | 14 | PS50235 |
| Domain | USP_dom | USP17L7 USP36 USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 5.84e-25 | 72 | 39 | 14 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP36 USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 5.84e-25 | 72 | 39 | 14 | IPR001394 |
| Domain | GroES-like | 1.67e-07 | 24 | 39 | 4 | IPR011032 | |
| Domain | ADH_Zn_CS | 4.68e-07 | 8 | 39 | 3 | IPR002328 | |
| Domain | ADH_ZINC | 4.68e-07 | 8 | 39 | 3 | PS00059 | |
| Domain | ADH_N | 4.63e-06 | 16 | 39 | 3 | PF08240 | |
| Domain | PKS_ER | 4.63e-06 | 16 | 39 | 3 | IPR020843 | |
| Domain | ADH_N | 4.63e-06 | 16 | 39 | 3 | IPR013154 | |
| Domain | PKS_ER | 4.63e-06 | 16 | 39 | 3 | SM00829 | |
| Domain | - | 6.72e-06 | 18 | 39 | 3 | 3.90.180.10 | |
| Domain | ADH_SF_Zn-type | 7.97e-06 | 19 | 39 | 3 | IPR002085 | |
| Domain | ADH_zinc_N | 7.97e-06 | 19 | 39 | 3 | PF00107 | |
| Domain | ADH_C | 7.97e-06 | 19 | 39 | 3 | IPR013149 | |
| Domain | Protein_kinase_C_a/b/g | 1.27e-05 | 3 | 39 | 2 | IPR014375 | |
| Domain | zf-DHHC | 1.45e-05 | 23 | 39 | 3 | PF01529 | |
| Domain | DHHC | 1.88e-05 | 25 | 39 | 3 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 1.88e-05 | 25 | 39 | 3 | IPR001594 | |
| Domain | LAMININ_NTER | 5.01e-04 | 16 | 39 | 2 | PS51117 | |
| Domain | Laminin_N | 5.01e-04 | 16 | 39 | 2 | PF00055 | |
| Domain | Laminin_N | 5.01e-04 | 16 | 39 | 2 | IPR008211 | |
| Domain | LamNT | 5.01e-04 | 16 | 39 | 2 | SM00136 | |
| Domain | DAG/PE-bd | 8.70e-04 | 21 | 39 | 2 | IPR020454 | |
| Domain | EGF_LAM_2 | 1.78e-03 | 30 | 39 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.78e-03 | 30 | 39 | 2 | PS01248 | |
| Domain | EGF_1 | 1.92e-03 | 255 | 39 | 4 | PS00022 | |
| Domain | EGF-like_CS | 2.09e-03 | 261 | 39 | 4 | IPR013032 | |
| Domain | Laminin_EGF | 2.42e-03 | 35 | 39 | 2 | PF00053 | |
| Domain | EGF_Lam | 2.42e-03 | 35 | 39 | 2 | SM00180 | |
| Domain | Pkinase_C | 2.70e-03 | 37 | 39 | 2 | IPR017892 | |
| Domain | Laminin_EGF | 2.85e-03 | 38 | 39 | 2 | IPR002049 | |
| Domain | Znf_FYVE | 2.85e-03 | 38 | 39 | 2 | IPR000306 | |
| Domain | ZF_FYVE | 3.15e-03 | 40 | 39 | 2 | PS50178 | |
| Domain | Pkinase_C | 3.47e-03 | 42 | 39 | 2 | PF00433 | |
| Domain | Znf_FYVE_PHD | 3.55e-03 | 147 | 39 | 3 | IPR011011 | |
| Domain | Growth_fac_rcpt_ | 4.19e-03 | 156 | 39 | 3 | IPR009030 | |
| Domain | - | 5.24e-03 | 169 | 39 | 3 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 5.59e-03 | 173 | 39 | 3 | IPR016040 | |
| Domain | AGC-kinase_C | 6.09e-03 | 56 | 39 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 6.09e-03 | 56 | 39 | 2 | PS51285 | |
| Domain | S_TK_X | 6.09e-03 | 56 | 39 | 2 | SM00133 | |
| Domain | C1_1 | 6.31e-03 | 57 | 39 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 7.89e-03 | 64 | 39 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 7.89e-03 | 64 | 39 | 2 | PS50081 | |
| Domain | C1 | 8.13e-03 | 65 | 39 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 8.38e-03 | 66 | 39 | 2 | IPR002219 | |
| Domain | - | 1.40e-02 | 449 | 39 | 4 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.50e-02 | 459 | 39 | 4 | IPR013083 | |
| Domain | Galactose-bd-like | 1.65e-02 | 94 | 39 | 2 | IPR008979 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 5.43e-28 | 45 | 32 | 14 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 HGS USP17L13 USP17L18 | 2.53e-20 | 191 | 32 | 15 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 HGS USP17L13 USP17L18 | 3.12e-18 | 262 | 32 | 15 | MM15286 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 HGS USP17L24 USP17L13 USP17L18 | 1.32e-17 | 221 | 32 | 14 | M27578 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 FN1 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 5.74e-17 | 318 | 32 | 15 | MM15278 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 HGS USP17L24 USP17L13 USP17L18 | 9.22e-16 | 299 | 32 | 14 | M27574 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 FBN1 USP17L12 FN1 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 HGS USP17L13 USP17L18 | 9.49e-10 | 1389 | 32 | 17 | MM15307 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | LAMB1 USP17L5 USP17L21 USP17L10 USP17L19 FBN1 USP17L12 FN1 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 HGS USP17L24 USP17L13 USP17L18 | 2.41e-09 | 1475 | 32 | 17 | M19806 |
| Pathway | REACTOME_ABACAVIR_ADME | 5.90e-07 | 8 | 32 | 3 | MM14869 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 1.26e-06 | 10 | 32 | 3 | MM15833 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.73e-06 | 11 | 32 | 3 | MM15405 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 2.31e-06 | 12 | 32 | 3 | M14663 | |
| Pathway | WP_COMPREHENSIVE_IL17A_SIGNALING | 4.49e-06 | 110 | 32 | 5 | MM16642 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 4.75e-06 | 15 | 32 | 3 | M39717 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 9.12e-06 | 59 | 32 | 4 | M27218 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 3.35e-05 | 28 | 32 | 3 | MM15188 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 4.57e-05 | 31 | 32 | 3 | M39714 | |
| Pathway | REACTOME_DISINHIBITION_OF_SNARE_FORMATION | 4.97e-05 | 5 | 32 | 2 | M26920 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 1.15e-04 | 42 | 32 | 3 | M699 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 1.15e-04 | 42 | 32 | 3 | M16743 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.23e-04 | 43 | 32 | 3 | M53 | |
| Pathway | WP_RETINOL_METABOLISM | 1.32e-04 | 44 | 32 | 3 | MM15851 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY | 1.39e-04 | 8 | 32 | 2 | M47479 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 1.39e-04 | 8 | 32 | 2 | M47555 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.51e-04 | 46 | 32 | 3 | MM1428 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.51e-04 | 46 | 32 | 3 | M19118 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.82e-04 | 49 | 32 | 3 | MM15186 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 2.22e-04 | 10 | 32 | 2 | M47644 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 2.71e-04 | 11 | 32 | 2 | M47637 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 3.25e-04 | 12 | 32 | 2 | M47597 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 3.25e-04 | 12 | 32 | 2 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 3.25e-04 | 12 | 32 | 2 | M47628 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 3.67e-04 | 62 | 32 | 3 | M11521 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 3.83e-04 | 13 | 32 | 2 | M47656 | |
| Pathway | KEGG_RETINOL_METABOLISM | 4.03e-04 | 64 | 32 | 3 | M9488 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.41e-04 | 66 | 32 | 3 | M18 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 4.47e-04 | 14 | 32 | 2 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 4.47e-04 | 14 | 32 | 2 | M47384 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4 | 5.15e-04 | 15 | 32 | 2 | M27413 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 5.15e-04 | 15 | 32 | 2 | M47382 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 5.25e-04 | 70 | 32 | 3 | M16794 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.30e-04 | 300 | 32 | 5 | M610 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 5.70e-04 | 72 | 32 | 3 | M9257 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 6.65e-04 | 17 | 32 | 2 | M212 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 6.65e-04 | 17 | 32 | 2 | M5488 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.47e-04 | 79 | 32 | 3 | M27643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 8.33e-04 | 19 | 32 | 2 | M47596 | |
| Pathway | WP_FOCAL_ADHESION | 1.02e-03 | 199 | 32 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.02e-03 | 199 | 32 | 4 | M7253 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 1.02e-03 | 21 | 32 | 2 | M47638 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.12e-03 | 22 | 32 | 2 | M27445 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 1.40e-03 | 98 | 32 | 3 | MM15942 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 1.57e-03 | 26 | 32 | 2 | M47557 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.66e-03 | 104 | 32 | 3 | M738 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.69e-03 | 27 | 32 | 2 | M27217 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.70e-03 | 105 | 32 | 3 | MM14842 | |
| Pathway | PID_IL8_CXCR1_PATHWAY | 1.82e-03 | 28 | 32 | 2 | M252 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.09e-03 | 30 | 32 | 2 | M207 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.09e-03 | 30 | 32 | 2 | M27772 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.09e-03 | 30 | 32 | 2 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.09e-03 | 30 | 32 | 2 | MM15812 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 2.23e-03 | 31 | 32 | 2 | M47554 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.23e-03 | 31 | 32 | 2 | M7223 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 2.37e-03 | 32 | 32 | 2 | M165 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.37e-03 | 32 | 32 | 2 | MM14854 | |
| Pathway | REACTOME_DRUG_ADME | 2.43e-03 | 119 | 32 | 3 | MM15692 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.52e-03 | 33 | 32 | 2 | M39503 | |
| Pathway | PID_IL8_CXCR2_PATHWAY | 2.68e-03 | 34 | 32 | 2 | M210 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.74e-03 | 124 | 32 | 3 | M27285 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.16e-03 | 37 | 32 | 2 | M27134 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 3.16e-03 | 37 | 32 | 2 | M749 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 3.26e-03 | 132 | 32 | 3 | M724 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 3.51e-03 | 39 | 32 | 2 | M39905 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.51e-03 | 39 | 32 | 2 | MM14601 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.85e-03 | 140 | 32 | 3 | M587 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.87e-03 | 41 | 32 | 2 | M27778 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 3.87e-03 | 41 | 32 | 2 | M39655 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.87e-03 | 41 | 32 | 2 | M512 | |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 4.06e-03 | 42 | 32 | 2 | M16473 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 4.25e-03 | 43 | 32 | 2 | M238 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 4.25e-03 | 43 | 32 | 2 | M27443 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.45e-03 | 44 | 32 | 2 | M26969 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 4.85e-03 | 46 | 32 | 2 | M239 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 4.85e-03 | 46 | 32 | 2 | M46450 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 5.28e-03 | 48 | 32 | 2 | M10775 | |
| Pathway | WP_TROP2_REGULATORY_SIGNALING | 5.49e-03 | 49 | 32 | 2 | M46458 | |
| Pathway | WP_WNT_SIGNALING_WP363 | 5.94e-03 | 51 | 32 | 2 | M39721 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 5.99e-03 | 325 | 32 | 4 | M12868 | |
| Pathway | WP_NETRINUNC5B_SIGNALING | 6.17e-03 | 52 | 32 | 2 | M39782 | |
| Pathway | PID_NFAT_3PATHWAY | 6.40e-03 | 53 | 32 | 2 | M113 | |
| Pathway | PID_CD8_TCR_PATHWAY | 6.40e-03 | 53 | 32 | 2 | M88 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 6.64e-03 | 54 | 32 | 2 | M19818 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 6.64e-03 | 54 | 32 | 2 | M26911 | |
| Pathway | KEGG_VIBRIO_CHOLERAE_INFECTION | 6.64e-03 | 54 | 32 | 2 | M17906 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 6.88e-03 | 55 | 32 | 2 | M39685 | |
| Pathway | PID_TXA2PATHWAY | 7.12e-03 | 56 | 32 | 2 | M99 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.41e-37 | 21 | 42 | 14 | 8622927 |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.41e-37 | 21 | 42 | 14 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.41e-37 | 21 | 42 | 14 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.41e-37 | 21 | 42 | 14 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.41e-37 | 21 | 42 | 14 | 12447969 |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.41e-37 | 21 | 42 | 14 | 18980247 | |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 3.88e-37 | 22 | 42 | 14 | 9154835 | |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.01e-36 | 33 | 42 | 15 | 20228807 | |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 20403174 | |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 17109758 | |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 20388806 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 14699124 |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 19188362 |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 11941478 | |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 10936051 | |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.80e-36 | 34 | 42 | 15 | 21448158 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 2.37e-36 | 24 | 42 | 14 | 8995226 |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 3.14e-36 | 35 | 42 | 15 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 3.14e-36 | 35 | 42 | 15 | 21239494 |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 5.39e-36 | 36 | 42 | 15 | 20147298 | |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 5.39e-36 | 25 | 42 | 14 | 21115691 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 9.05e-36 | 37 | 42 | 15 | 20228808 |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.17e-35 | 26 | 42 | 14 | 35816173 | |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 9.35e-35 | 29 | 42 | 14 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.11e-30 | 50 | 42 | 14 | 31806660 |
| Pubmed | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 FBN1 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.07e-15 | 674 | 42 | 15 | 37196079 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 NTN4 USP17L19 USP17L12 USP17L17 USP17L20 USP17L11 USP17L18 | 1.58e-12 | 119 | 42 | 8 | 28625976 |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 1.64e-09 | 3 | 42 | 3 | 10424757 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 11960985 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 2474823 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 2737681 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 1.64e-09 | 3 | 42 | 3 | 23772048 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 8163197 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 1.64e-09 | 3 | 42 | 3 | 24787690 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 2347582 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 3011597 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 6756216 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 1.64e-09 | 3 | 42 | 3 | 7748347 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 37806378 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 7840644 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 3006456 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 1.64e-09 | 3 | 42 | 3 | 9145544 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 1.64e-09 | 3 | 42 | 3 | 6816803 | |
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 1.64e-09 | 3 | 42 | 3 | 15670660 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 1.64e-09 | 3 | 42 | 3 | 15554233 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 35354963 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 6370228 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 8018987 | ||
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 1.64e-09 | 3 | 42 | 3 | 33586683 | |
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 1.64e-09 | 3 | 42 | 3 | 3157987 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 2169444 | ||
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 1.64e-09 | 3 | 42 | 3 | 8486690 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 2935875 | ||
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 1.64e-09 | 3 | 42 | 3 | 16801720 | |
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 11893554 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 29663519 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 12851412 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 9733106 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 36224745 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 9202249 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 8813054 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 19618839 | ||
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 6.54e-09 | 4 | 42 | 3 | 3996732 | |
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 9241435 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 10880953 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 12631290 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 2893758 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 9002638 | ||
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 15193143 | ||
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 8892527 | ||
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 11836246 | ||
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 8621625 | ||
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 7026729 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 1.63e-08 | 5 | 42 | 3 | 19193628 | |
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 1316195 | ||
| Pubmed | Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation. | 1.63e-08 | 5 | 42 | 3 | 39287388 | |
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 1.63e-08 | 5 | 42 | 3 | 22079585 | |
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 10358022 | ||
| Pubmed | 1.63e-08 | 5 | 42 | 3 | 7738026 | ||
| Pubmed | 3.27e-08 | 6 | 42 | 3 | 17257171 | ||
| Pubmed | 3.27e-08 | 6 | 42 | 3 | 26807981 | ||
| Pubmed | 3.27e-08 | 6 | 42 | 3 | 12027900 | ||
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 3.27e-08 | 6 | 42 | 3 | 16121213 | |
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 3.27e-08 | 6 | 42 | 3 | 9982 | |
| Pubmed | 3.27e-08 | 6 | 42 | 3 | 518534 | ||
| Pubmed | Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. | 3.27e-08 | 6 | 42 | 3 | 17185388 | |
| Pubmed | 5.71e-08 | 7 | 42 | 3 | 16047160 | ||
| Pubmed | 5.71e-08 | 7 | 42 | 3 | 11784316 | ||
| Pubmed | 5.71e-08 | 7 | 42 | 3 | 16685648 | ||
| Pubmed | Androgen regulation of gene expression in primary epithelial cells of the mouse kidney. | 5.71e-08 | 7 | 42 | 3 | 8119157 | |
| Pubmed | 5.71e-08 | 7 | 42 | 3 | 37953328 | ||
| Pubmed | 5.71e-08 | 7 | 42 | 3 | 23456092 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 5.71e-08 | 7 | 42 | 3 | 23468174 | |
| Interaction | FLT3 interactions | USP17L21 NTN4 USP17L19 USP17L12 USP17L17 USP17L20 USP17L11 USP17L18 | 1.41e-07 | 318 | 39 | 8 | int:FLT3 |
| Interaction | ADH1B interactions | 1.89e-06 | 13 | 39 | 3 | int:ADH1B | |
| Interaction | PA2G4 interactions | 1.64e-05 | 284 | 39 | 6 | int:PA2G4 | |
| Interaction | ADH1A interactions | 3.64e-05 | 5 | 39 | 2 | int:ADH1A | |
| Cytoband | 4p16.1 | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L23 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 7.94e-32 | 79 | 42 | 15 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L23 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.01e-24 | 222 | 42 | 15 | chr4p16 |
| Cytoband | 4q23 | 8.03e-07 | 20 | 42 | 3 | 4q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 5.41e-06 | 37 | 42 | 3 | chr4q23 | |
| GeneFamily | Alcohol dehydrogenases | 1.15e-07 | 8 | 24 | 3 | 397 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 4.08e-06 | 24 | 24 | 3 | 76 | |
| GeneFamily | C2 domain containing protein kinases | 7.55e-05 | 10 | 24 | 2 | 835 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L6P USP17L5 PRKCA USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 4.01e-26 | 112 | 40 | 15 | MM1095 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.19e-25 | 86 | 40 | 14 | MM1312 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.13e-21 | 160 | 40 | 14 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 TRAFD1 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.49e-14 | 647 | 40 | 15 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 USP17L6P USP17L5 PRKCA USP17L21 USP17L10 USP17L19 MLLT10 USP17L12 FN1 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 MIB1 | 2.91e-14 | 1198 | 40 | 18 | MM1062 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 ADH1A ADH1B USP17L18 ADH1C | 8.07e-14 | 1072 | 40 | 17 | MM1031 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 TRAFD1 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.38e-10 | 1226 | 40 | 15 | MM979 |
| Coexpression | GSE17721_POLYIC_VS_CPG_1H_BMDC_DN | 1.30e-05 | 200 | 40 | 5 | M3936 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.92e-05 | 369 | 40 | 6 | MM16610 | |
| Coexpression | BROWNE_HCMV_INFECTION_2HR_UP | 3.13e-05 | 40 | 40 | 3 | M3649 | |
| Coexpression | MCDOWELL_ACUTE_LUNG_INJURY_DN | 6.91e-05 | 52 | 40 | 3 | MM693 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 1.05e-04 | 310 | 40 | 5 | MM16608 | |
| Coexpression | IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP | 1.48e-04 | 12 | 40 | 2 | M5071 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.61e-04 | 69 | 40 | 3 | M10165 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_0HR | 1.61e-04 | 69 | 40 | 3 | MM1024 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 1.98e-04 | 74 | 40 | 3 | M4479 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.98e-04 | 74 | 40 | 3 | M13547 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.03e-04 | 191 | 40 | 4 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.24e-04 | 196 | 40 | 4 | M3008 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN | 2.42e-04 | 200 | 40 | 4 | M7178 | |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN | 2.42e-04 | 200 | 40 | 4 | M6715 | |
| Coexpression | GSE11924_TFH_VS_TH2_CD4_TCELL_UP | 2.42e-04 | 200 | 40 | 4 | M3153 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN | 2.42e-04 | 200 | 40 | 4 | M5697 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 3.08e-04 | 213 | 40 | 4 | M12176 | |
| Coexpression | AIZARANI_LIVER_C17_HEPATOCYTES_3 | 5.09e-04 | 102 | 40 | 3 | M39119 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P4 | 5.70e-04 | 106 | 40 | 3 | MM1216 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT | 6.14e-04 | 24 | 40 | 2 | M38986 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 6.18e-04 | 109 | 40 | 3 | MM1214 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 6.52e-04 | 111 | 40 | 3 | MM705 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-07 | 176 | 34 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-07 | 176 | 34 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-07 | 181 | 34 | 5 | 091e7975badd1ffa463a8ec87908be20781ecfd6 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.81e-07 | 185 | 34 | 5 | 46460e74cc613df9043f5404e7342aa13cc34873 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.89e-07 | 186 | 34 | 5 | 88e6246172d816806a498a5c1f38e699f2f5d7c2 | |
| ToppCell | P15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.05e-07 | 188 | 34 | 5 | f1ba0b661621a65c91432e62ba73531bdf18e7c1 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 6.41e-06 | 159 | 34 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.25e-06 | 164 | 34 | 4 | a764b79a127c8f360af0b79a1da64658badf0dfa | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 7.25e-06 | 164 | 34 | 4 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.97e-06 | 168 | 34 | 4 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.97e-06 | 168 | 34 | 4 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.16e-06 | 169 | 34 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-05 | 181 | 34 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-05 | 181 | 34 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.09e-05 | 182 | 34 | 4 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 182 | 34 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.09e-05 | 182 | 34 | 4 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 186 | 34 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.22e-05 | 187 | 34 | 4 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.22e-05 | 187 | 34 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 1.24e-05 | 188 | 34 | 4 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 189 | 34 | 4 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 189 | 34 | 4 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 189 | 34 | 4 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.27e-05 | 189 | 34 | 4 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | 00fd993675faf53adf985b9316a18c8a33242029 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.29e-05 | 190 | 34 | 4 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.29e-05 | 190 | 34 | 4 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.29e-05 | 190 | 34 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | 8cda09d761c6b504a744959d587c183f94f1beeb | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-05 | 191 | 34 | 4 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-05 | 191 | 34 | 4 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-05 | 191 | 34 | 4 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.32e-05 | 191 | 34 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-05 | 191 | 34 | 4 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-05 | 191 | 34 | 4 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-05 | 191 | 34 | 4 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-05 | 191 | 34 | 4 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-05 | 192 | 34 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-05 | 192 | 34 | 4 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 192 | 34 | 4 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 192 | 34 | 4 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 192 | 34 | 4 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 193 | 34 | 4 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 193 | 34 | 4 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 193 | 34 | 4 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.38e-05 | 193 | 34 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 193 | 34 | 4 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 193 | 34 | 4 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-05 | 193 | 34 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.38e-05 | 193 | 34 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.38e-05 | 193 | 34 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.40e-05 | 194 | 34 | 4 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.40e-05 | 194 | 34 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-05 | 194 | 34 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 194 | 34 | 4 | d47e3c7b22444aef0c7a37bc8cd8853b590a56dd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-05 | 194 | 34 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 194 | 34 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-05 | 194 | 34 | 4 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.40e-05 | 194 | 34 | 4 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.40e-05 | 194 | 34 | 4 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.40e-05 | 194 | 34 | 4 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.43e-05 | 195 | 34 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.43e-05 | 195 | 34 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 195 | 34 | 4 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | cbe518b465b4ef32797ae6b608219207c08493df | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 195 | 34 | 4 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | 6bb6349d6ec8da094fe1c7c590021989337aeb0b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.43e-05 | 195 | 34 | 4 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 195 | 34 | 4 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.43e-05 | 195 | 34 | 4 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | 136b06b0931a69b1241101f68c01c44c70365fd9 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | a3b468125e48f072255cede7645f6692298ecf54 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.43e-05 | 195 | 34 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 195 | 34 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.46e-05 | 196 | 34 | 4 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 196 | 34 | 4 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 196 | 34 | 4 | 2a885eed52f9b002c7995e11e450c7e8d7ae69e6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-05 | 196 | 34 | 4 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 196 | 34 | 4 | 14246f00c90741a5f8683f377e22e3a7c99661b9 | |
| ToppCell | E17.5-Mesenchymal|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.46e-05 | 196 | 34 | 4 | b4ee991445b612506372b9361ebfe72cb59b811e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 196 | 34 | 4 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-05 | 196 | 34 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 196 | 34 | 4 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-05 | 196 | 34 | 4 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | PND07-Mesenchymal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 196 | 34 | 4 | 0050c7134473fbfd7b9f0ae8d6d337713e60b57d | |
| ToppCell | MatrixFB|World / shred on cell class and cell subclass (v4) | 1.49e-05 | 197 | 34 | 4 | e325de44e32021a36fffb7b7e88167b46bb051c7 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 197 | 34 | 4 | 06a0d7062dadda656decaf77dcef9a10b5f2698d | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 197 | 34 | 4 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 197 | 34 | 4 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 197 | 34 | 4 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | PND01-Mesenchymal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 197 | 34 | 4 | 292b8cc3dafddf5d323fe4e3d3ea5ac61e6ce027 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.49e-05 | 197 | 34 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 197 | 34 | 4 | d35c7a36135b5ed6a7bf2f934849678eba2a0177 | |
| Computational | Oxidoreductases. | 4.97e-06 | 22 | 17 | 3 | MODULE_373 | |
| Computational | Neighborhood of CDH11 | 7.40e-06 | 25 | 17 | 3 | GNF2_CDH11 | |
| Computational | Neighborhood of IGFBP1 | 9.12e-05 | 57 | 17 | 3 | CAR_IGFBP1 | |
| Computational | Genes in the cancer module 514. | 1.05e-04 | 10 | 17 | 2 | MODULE_514 | |
| Computational | DRG (dorsal root ganglia) genes. | 2.46e-04 | 384 | 17 | 5 | MODULE_2 | |
| Computational | Genes in the cancer module 248. | 1.02e-03 | 129 | 17 | 3 | MODULE_248 | |
| Computational | Metal / Ca ion binding. | 1.11e-03 | 133 | 17 | 3 | MODULE_324 | |
| Computational | Adhesion molecules. | 1.31e-03 | 141 | 17 | 3 | MODULE_122 | |
| Computational | Neighborhood of PTX3 | 1.44e-03 | 36 | 17 | 2 | GNF2_PTX3 | |
| Computational | Genes in the cancer module 286 | 1.52e-03 | 37 | 17 | 2 | MODULE_286 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.65e-03 | 49 | 17 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.76e-03 | 50 | 17 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Drug | 4-Iodopyrazole | 1.86e-09 | 3 | 29 | 3 | DB02721 | |
| Drug | Fomepizole | 7.42e-09 | 4 | 29 | 3 | DB01213 | |
| Drug | Ethanol | 6.48e-08 | 7 | 29 | 3 | DB00898 | |
| Drug | N-heptylformamide | 1.04e-07 | 8 | 29 | 3 | CID000347402 | |
| Drug | 2-NA | 1.55e-07 | 9 | 29 | 3 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 1.55e-07 | 9 | 29 | 3 | CID000440672 | |
| Drug | AC1L1J0I | 4.06e-07 | 12 | 29 | 3 | CID000030201 | |
| Drug | hexa-2,4-dien-1-ol | 4.06e-07 | 12 | 29 | 3 | CID000008104 | |
| Drug | 2-naphthaldehyde | 5.27e-07 | 13 | 29 | 3 | CID000006201 | |
| Drug | 3-methylbutanal | 5.27e-07 | 13 | 29 | 3 | CID000011552 | |
| Drug | naphthalenemethanol | 6.70e-07 | 14 | 29 | 3 | CID000020908 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 8.37e-07 | 15 | 29 | 3 | CID000440673 | |
| Drug | phenoxyethanol | 1.03e-06 | 16 | 29 | 3 | CID000031236 | |
| Drug | naphthaldehyde | 1.03e-06 | 16 | 29 | 3 | CID000006195 | |
| Drug | C x F | 1.78e-06 | 19 | 29 | 3 | CID000013017 | |
| Drug | Peony | 2.09e-06 | 20 | 29 | 3 | CID005483934 | |
| Drug | 4-iodopyrazole | 2.43e-06 | 21 | 29 | 3 | CID000077022 | |
| Drug | ALT-711 | 2.43e-06 | 21 | 29 | 3 | CID000216304 | |
| Drug | Ethylene Glycol | 2.43e-06 | 21 | 29 | 3 | ctd:D019855 | |
| Drug | MDL 27,032 | 2.43e-06 | 21 | 29 | 3 | CID000163812 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 3.64e-06 | 83 | 29 | 4 | CID011968896 | |
| Drug | acetaldehyde | 3.65e-06 | 338 | 29 | 6 | CID000000177 | |
| Drug | 2-butoxyethanol | 3.69e-06 | 24 | 29 | 3 | CID000008133 | |
| Drug | 4-methylpiperazine-2,6-dione | 4.74e-06 | 26 | 29 | 3 | CID000124723 | |
| Drug | AC1L1G9W | 5.25e-06 | 91 | 29 | 4 | CID000003592 | |
| Drug | fomepizole | 5.32e-06 | 27 | 29 | 3 | ctd:C010238 | |
| Drug | AC1L1B58 | 6.64e-06 | 29 | 29 | 3 | CID000001288 | |
| Drug | dhmal | 6.64e-06 | 29 | 29 | 3 | CID000151725 | |
| Drug | AC1L1AOQ | 7.37e-06 | 30 | 29 | 3 | CID000001082 | |
| Drug | Methanol | 8.15e-06 | 31 | 29 | 3 | ctd:D000432 | |
| Drug | willardine | 8.99e-06 | 32 | 29 | 3 | CID000005123 | |
| Drug | walrycin A | 8.99e-06 | 32 | 29 | 3 | ctd:C574123 | |
| Drug | DOPEG | 1.29e-05 | 36 | 29 | 3 | CID000091528 | |
| Drug | 3-hydroxynonanoate | 1.56e-05 | 5 | 29 | 2 | CID000036599 | |
| Drug | 3-hydroxyundecanoate | 1.56e-05 | 5 | 29 | 2 | CID003083221 | |
| Drug | N-1-methylheptylformamide | 1.56e-05 | 5 | 29 | 2 | CID005478865 | |
| Drug | 2-Propanol | 1.65e-05 | 39 | 29 | 3 | ctd:D019840 | |
| Drug | Nicotinamide-Adenine-Dinucleotide | 1.78e-05 | 40 | 29 | 3 | DB01907 | |
| Drug | S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (2R)-2-[4-(2-methylpropyl)phenyl]propanethioate | 1.92e-05 | 41 | 29 | 3 | CID009854504 | |
| Drug | 1-MCP | 1.92e-05 | 41 | 29 | 3 | CID000151080 | |
| Drug | calphostin C | 1.92e-05 | 41 | 29 | 3 | ctd:C058819 | |
| Drug | AC1Q5V5T | 2.50e-05 | 135 | 29 | 4 | CID000004701 | |
| Drug | trypanothione disulfide | 2.89e-05 | 140 | 29 | 4 | CID000115098 | |
| Drug | 3-butylthiolane 1-oxide | 3.28e-05 | 7 | 29 | 2 | CID003363251 | |
| Drug | Nile red | 3.50e-05 | 50 | 29 | 3 | CID000065182 | |
| Drug | EGEE | 3.71e-05 | 51 | 29 | 3 | CID000008076 | |
| Drug | Finrazole | 3.71e-05 | 51 | 29 | 3 | CID000178036 | |
| Drug | auranofin | 3.94e-05 | 52 | 29 | 3 | CID006918453 | |
| Drug | 5-butyl-2-phenoxyphenol | 4.37e-05 | 8 | 29 | 2 | CID005274975 | |
| Drug | AC1NBLOP | 4.37e-05 | 8 | 29 | 2 | CID004469995 | |
| Drug | 3-keto-LCA | 4.37e-05 | 8 | 29 | 2 | CID000159623 | |
| Drug | I-Q-S | 4.41e-05 | 156 | 29 | 4 | CID000003540 | |
| Drug | Ridauran | 4.66e-05 | 55 | 29 | 3 | CID006333887 | |
| Drug | cysteinylglycine | 5.19e-05 | 57 | 29 | 3 | CID000065270 | |
| Drug | 12-oxododecanoic acid | 5.61e-05 | 9 | 29 | 2 | CID000077563 | |
| Drug | UDP-alpha-d-xylopyranose | 6.05e-05 | 60 | 29 | 3 | CID000001165 | |
| Drug | DB04780 | 6.16e-05 | 170 | 29 | 4 | CID005459389 | |
| Drug | allyl alcohol | 7.35e-05 | 64 | 29 | 3 | CID000007858 | |
| Drug | 1,5-AG | 8.02e-05 | 182 | 29 | 4 | CID000064960 | |
| Drug | octanol | 8.05e-05 | 66 | 29 | 3 | CID000000957 | |
| Drug | BM165 | 8.55e-05 | 11 | 29 | 2 | CID003352881 | |
| Drug | 4,4'-dichlorobiphenyl | 8.55e-05 | 11 | 29 | 2 | CID000016308 | |
| Drug | cepharanthine | 9.60e-05 | 70 | 29 | 3 | CID000010206 | |
| Drug | AC1L590V | 1.03e-04 | 12 | 29 | 2 | CID000172417 | |
| Drug | heptadecane | 1.03e-04 | 12 | 29 | 2 | CID000012398 | |
| Drug | bryostatin 1 | 1.03e-04 | 12 | 29 | 2 | ctd:C046785 | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 194 | 29 | 4 | 5316_DN | |
| Drug | 2,2,2-trichloroethanol | 1.09e-04 | 73 | 29 | 3 | CID000008259 | |
| Drug | S-dC28 | 1.21e-04 | 13 | 29 | 2 | CID000159480 | |
| Drug | 2-amino-3-phosphonopropionic acid | 1.23e-04 | 76 | 29 | 3 | CID000003857 | |
| Drug | Cimetidine | 1.23e-04 | 76 | 29 | 3 | ctd:D002927 | |
| Drug | methyl 2,5-dihydroxycinnamate | 1.28e-04 | 77 | 29 | 3 | CID000003248 | |
| Drug | YIGSR | 1.38e-04 | 79 | 29 | 3 | CID000123977 | |
| Drug | tinyatoxin | 1.41e-04 | 14 | 29 | 2 | CID000005481 | |
| Drug | euxanthone | 1.41e-04 | 14 | 29 | 2 | CID005281631 | |
| Drug | benzyl alcohol | 1.59e-04 | 83 | 29 | 3 | CID000000244 | |
| Drug | RK-1409B | 1.63e-04 | 15 | 29 | 2 | CID003036125 | |
| Drug | dansyl-DAG | 1.63e-04 | 15 | 29 | 2 | CID000129493 | |
| Drug | 1-stearoyl-2-arachidonylglycerol | 1.63e-04 | 15 | 29 | 2 | CID006443869 | |
| Drug | 3-hydroxyoctanoate | 1.63e-04 | 15 | 29 | 2 | CID000026613 | |
| Drug | 4-methylpyrazole | 1.65e-04 | 84 | 29 | 3 | CID000003406 | |
| Drug | Sas 1 | 1.86e-04 | 16 | 29 | 2 | CID006328170 | |
| Drug | piperazine dihydrochloride | 1.86e-04 | 16 | 29 | 2 | CID000008893 | |
| Drug | azoxystrobin | 1.90e-04 | 88 | 29 | 3 | CID003034285 | |
| Drug | poly-N-acetyllactosamine | 1.90e-04 | 88 | 29 | 3 | CID000119547 | |
| Drug | hydroxyl radicals | 2.00e-04 | 1341 | 29 | 8 | CID000000961 | |
| Drug | H-9 dihydrochloride | 2.03e-04 | 90 | 29 | 3 | CID000003544 | |
| Drug | PGDM | 2.11e-04 | 17 | 29 | 2 | CID006441790 | |
| Drug | daphnoretin | 2.11e-04 | 17 | 29 | 2 | CID005281406 | |
| Drug | AC1L1JQC | 2.11e-04 | 17 | 29 | 2 | CID000005157 | |
| Drug | AC1L1G3W | 2.22e-04 | 237 | 29 | 4 | CID000003514 | |
| Drug | dipalmitin | 2.37e-04 | 18 | 29 | 2 | CID000068149 | |
| Drug | resiniferonol | 2.37e-04 | 18 | 29 | 2 | CID000162824 | |
| Drug | Cgp-42700 | 2.37e-04 | 18 | 29 | 2 | CID000188390 | |
| Drug | amrubicin | 2.37e-04 | 18 | 29 | 2 | CID000114897 | |
| Drug | dihydrosterculic acid | 2.37e-04 | 18 | 29 | 2 | CID000160788 | |
| Drug | 3H-DA | 2.37e-04 | 18 | 29 | 2 | CID000026612 | |
| Drug | Bq123 | 2.38e-04 | 95 | 29 | 3 | CID000443289 | |
| Drug | pentadecane | 2.64e-04 | 19 | 29 | 2 | CID000012391 | |
| Drug | TAPP-Br | 2.64e-04 | 19 | 29 | 2 | CID000160326 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP36 USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 3.87e-36 | 46 | 40 | 16 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP36 USP17L6P USP17L5 USP17L21 USP17L10 CHD6 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.87e-35 | 69 | 40 | 17 | DOID:1682 (implicated_via_orthology) |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 1.74e-05 | 37 | 40 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | ALCOHOL DEPENDENCE | 1.79e-05 | 5 | 40 | 2 | 103780 | |
| Disease | Alcohol dependence | 1.79e-05 | 5 | 40 | 2 | cv:C0001973 | |
| Disease | alcohol dependence measurement | 5.77e-05 | 55 | 40 | 3 | EFO_0007835 | |
| Disease | Alcohol abuse | 1.04e-04 | 67 | 40 | 3 | C0085762 | |
| Disease | Non-alcoholic Fatty Liver Disease | 1.19e-04 | 70 | 40 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 1.19e-04 | 70 | 40 | 3 | C3241937 | |
| Disease | alcohol use disorder (is_implicated_in) | 2.12e-04 | 16 | 40 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | syndrome (implicated_via_orthology) | 2.70e-04 | 18 | 40 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 3.70e-04 | 21 | 40 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 4.85e-04 | 24 | 40 | 2 | EFO_0009458, MONDO_0007079 | |
| Disease | parental emotion expression measurmement, conduct disorder | 5.27e-04 | 25 | 40 | 2 | EFO_0004216, EFO_0008342 | |
| Disease | Alcoholic Intoxication | 8.66e-04 | 32 | 40 | 2 | C0001969 | |
| Disease | Alcohol Use Disorder | 1.64e-03 | 44 | 40 | 2 | C0001956 | |
| Disease | end stage renal disease (is_marker_for) | 1.79e-03 | 46 | 40 | 2 | DOID:783 (is_marker_for) | |
| Disease | alcohol dependence | 1.96e-03 | 183 | 40 | 3 | MONDO_0007079 | |
| Disease | substance-related disorder | 2.28e-03 | 52 | 40 | 2 | MONDO_0002494 | |
| Disease | gout | 2.38e-03 | 196 | 40 | 3 | EFO_0004274 | |
| Disease | Mouth Neoplasms | 2.45e-03 | 54 | 40 | 2 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 2.45e-03 | 54 | 40 | 2 | C0153381 | |
| Disease | ecosanoids measurement | 2.54e-03 | 55 | 40 | 2 | EFO_0020044 | |
| Disease | isoleucine measurement | 2.63e-03 | 56 | 40 | 2 | EFO_0009793 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MMASLLCCHEACGTS | 276 | P07327 | |
| MMASLLCCHEACGTS | 276 | P00325 | |
| MMASLLCCHEACGTS | 276 | P00326 | |
| TNSTCCGRCHAPMHM | 321 | Q9HBW1 | |
| EGMVHGHCMCRHNTK | 291 | P07942 | |
| HQGMKCSCCEMNVHR | 126 | P05129 | |
| CGHMCACENCANLMK | 881 | Q86YT6 | |
| CQCHCKHMERWMHGL | 1936 | Q8TD26 | |
| KQHDMGHMMRCTCVG | 486 | P02751 | |
| THMCSQHADCKNTMG | 1371 | P35555 | |
| HMLCNSCLTMHVGSR | 86 | Q3SY46 | |
| CHAHMTCHCGEEAMK | 126 | Q9NYY1 | |
| SSCCMMLHMLNGCHP | 581 | Q99558 | |
| MLRSKMGKCCHHCFP | 56 | B2RU33 | |
| METHMAAEHCQVTCK | 51 | O14545 | |
| IHQGMKCDTCDMNVH | 126 | P17252 | |
| FHMVHGKCMCKHNTA | 286 | Q9HB63 | |
| CGHMVTCTKCGKRMN | 331 | Q8WZ73 | |
| HSMKEMIGGCCVCSD | 16 | P55197 | |
| RSHHCRKCNRCVMKM | 111 | Q9H6R6 | |
| RKCNRCVMKMDHHCP | 116 | Q9H6R6 | |
| HCSACDSCILKMDHH | 141 | Q5W0Z9 | |
| TCHRHKGCMLCTMQA | 116 | D6R9N7 | |
| MTRKHHCRACGQIFC | 176 | O14964 | |
| TCHRHKGCMLCTMQA | 116 | A8MUK1 | |
| CGACAKHFHTMAAMK | 646 | O15015 | |
| TCHRHKGCMLCTMQA | 116 | D6R901 | |
| TCHRHKGCMLCTMQA | 116 | C9JLJ4 | |
| HSCARCPANMCKHKV | 166 | Q8TCT1 | |
| TCHRHKGCMLCTMQA | 116 | D6RCP7 | |
| TCHRHKGCMLCTMQA | 116 | C9JPN9 | |
| TCHRHKGCMLCTMQA | 116 | Q0WX57 | |
| TCHLHKCCMFCTMQA | 116 | P0C7H9 | |
| TCHRHKGCMLCTMQA | 116 | Q6QN14 | |
| TCHRHKGCMLCTMQA | 116 | D6RA61 | |
| TCHRHKGCMLCTMQA | 116 | C9J2P7 | |
| TCHRHKGCMLCTMQA | 116 | D6RBQ6 | |
| TCHRHKGCMLCTMQA | 116 | D6RBM5 | |
| ARSCHQGSFCMLCVM | 156 | Q9P275 | |
| TCHRHKGCMLCTMQA | 116 | D6RJB6 | |
| TCHRHKGCMLCTMQA | 116 | C9JJH3 | |
| RCHHCSVCAMCVLKM | 141 | Q96MV8 | |
| SVCAMCVLKMDHHCP | 146 | Q96MV8 | |
| TCHRHKGCMLCTMQA | 116 | C9JVI0 |